Caricamento...
Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes
The quest for “personalized medicine” in psychiatry has focused mainly on pursuing potential biomarkers such as pharmacogenetic predictors of drug response. However, the collective randomized trial database across phases of bipolar disorder allows one to identify clinical characteristics that inform...
Salvato in:
| Pubblicato in: | Focus (Am Psychiatr Publ) |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Psychiatric Association
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6999206/ https://ncbi.nlm.nih.gov/pubmed/32047366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.focus.20190005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|